Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Am J Clin Dermatol ; 25(4): 609-621, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38755503

RESUMO

Drug reaction with eosinophilia and systemic symptoms (DReSS) is known to cause mortality and long-term sequelae in the pediatric population, however there are no established clinical practice guidelines for the management of pediatric DReSS. We conducted a scoping review, according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, to summarize the currently available data on treatment, mortality, and long-term sequelae of DReSS in children (aged 0-18 years). Data from 644 individuals revealed that various treatment strategies are being used in the management of pediatric DReSS, and strategies were often used in combination. The diversity in treatment approaches cannot be solely attributed to age or disease severity and reflects the lack of evidence-based management guidelines for DReSS. Children are also at risk of developing autoimmune sequelae following DReSS, most commonly thyroid disease and type 1 diabetes mellitus. We found that the eventual development of autoimmune disease was more often associated with DReSS caused by antibiotics, especially minocycline and sulfamethoxazole, in comparison with individuals who did not develop sequelae. In this study, we identify strengths and weaknesses in the currently available literature and highlight that future prospective studies with structured and long-term follow-up of children with DReSS are needed to better understand potential risk factors for mortality and development of sequelae after DReSS.


Assuntos
Síndrome de Hipersensibilidade a Medicamentos , Humanos , Síndrome de Hipersensibilidade a Medicamentos/etiologia , Síndrome de Hipersensibilidade a Medicamentos/diagnóstico , Síndrome de Hipersensibilidade a Medicamentos/terapia , Criança , Adolescente , Pré-Escolar , Lactente , Fatores de Risco , Antibacterianos/efeitos adversos , Resultado do Tratamento , Doenças Autoimunes/induzido quimicamente , Índice de Gravidade de Doença
2.
Clin Rev Allergy Immunol ; 66(1): 112-123, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-38466562

RESUMO

Effective treatment of drug reactions with eosinophilia and systemic symptoms (DReSS) requires early diagnosis and close monitoring. Diagnosing DReSS is especially challenging in children due to a low incidence rate, heterogeneous clinical presentation, and a lack of (pediatric) diagnostic criteria and clinical practice guidelines. We performed a scoping review, according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, to summarize the clinical presentation and diagnostic process of DReSS in children (aged 0-18 years). Data from 644 individuals showed that DReSS manifests differently in children compared to adults. Children have a higher number of organs involved, including higher rates of cardiac and respiratory involvement compared to adults. Children < 6 years of age appear more prone to develop neurologic symptoms. Conversely, eosinophilia, edema, and kidney involvement are less frequently observed in children. Anti-seizure medications are by far the most common causative drug class, but the range of implicated drugs increases as children get older. This study highlights that children with DReSS not only differ from adults but also that differences exist between children of different ages. As such, there is a need to establish pediatric-specific diagnostic criteria. These efforts will promote earlier diagnosis of DReSS and likely lead to improved clinical care offered to children and their families.


Assuntos
Síndrome de Hipersensibilidade a Medicamentos , Humanos , Criança , Síndrome de Hipersensibilidade a Medicamentos/diagnóstico , Síndrome de Hipersensibilidade a Medicamentos/etiologia , Adolescente , Pré-Escolar , Lactente , Recém-Nascido , Fatores Etários
3.
East Mediterr Health J ; 25(7): 465-472, 2019 Oct 04.
Artigo em Inglês | MEDLINE | ID: mdl-31612978

RESUMO

BACKGROUND: Childhood obesity is on the increase in the Middle East. AIMS: This study aimed to determine the prevalence of obesity in those aged six to eight years and to investigate maternal perception of child weight. METHODS: A nation-wide study of data on height and weight were obtained from nurses' records, and maternal perceptions were assessed through a self-administered questionnaire. Sample size comprised 2208 individuals with BMI measurements and 1002 with BMI and maternal perception data. RESULTS: The prevalence of overweight and obese children combined was 40.9% as per WHO cut-off values and 39.7% as per Centres for Disease Control and Prevention categorizations. We also found that 77.9% of overweight and 45.4% of obese children were perceived by their mothers to have healthy body weights. Additionally, 39.8% of children with normal weight were also judged by their mothers to be underweight. CONCLUSIONS: An alarmingly high prevalence of childhood obesity among Kuwaiti children, coupled with mothers distorted perception of their child's actual weight status is a serious concern that requires urgent public health intervention.


Assuntos
Mães/psicologia , Obesidade Infantil/epidemiologia , Índice de Massa Corporal , Criança , Estudos Transversais , Feminino , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Kuweit/epidemiologia , Masculino , Sobrepeso/epidemiologia , Percepção , Fatores Socioeconômicos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA